Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-06-21 Transaction in Own Shar…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's share buy-back activity, including daily updates on the number of shares bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' and 'Daily buy-back notification' multiple times, indicating it is a report on the company's repurchase of its own shares. This fits the definition of a 'Transaction in Own Shares' filing, which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document is not an announcement of a report, nor is it a financial report or regulatory certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-06-21 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's on-market share buy-back activity, including daily updates on the number of securities bought back, prices paid, broker information, and key dates. It specifically mentions 'Notification of buy-back' multiple times and provides daily buy-back figures. This matches the description of a report on the company's repurchase of its own shares. According to the filing definitions, reports about the company buying back or selling its own shares fall under 'Transaction in Own Shares' (POS). The document is not an announcement of a report but the actual notification of the buy-back activity, and it contains substantive data about the transactions. Therefore, the correct classification is POS.
2023-06-20 English
Becoming a substantial holder 7 pages 1.6MB
Regulatory Filings
2023-06-18 English
Mithra announces sale of Mayne Pharma shares 3 pages 246.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated June 19, 2023, regarding the sale of shares by Mithra Pharmaceuticals in Mayne Pharma. It details the number of shares sold, the reduction in stake, and the ongoing collaboration between the companies. The text includes statements about the transaction, shareholding percentages, and strategic intentions but does not contain any financial statements, detailed financial performance data, or comprehensive report content. It is a regulatory announcement about a share sale transaction and ownership update. The document length is 7264 characters, which is sufficient for a detailed announcement but does not constitute a full financial report or earnings release. Therefore, the document fits best into the category of Capital/Financing Update (CAP), as it provides an update on shareholding and capital structure changes due to the sale of shares.
2023-06-18 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, broker details, dates of buy-back start and end, and compliance with listing rules. The content focuses exclusively on the company's share repurchase activity and does not contain financial statements, earnings data, or other report types. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buy-back or sale of its own shares.
2023-06-14 English
Ceasing to be a substantial holder 4 pages 567.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001, detailing changes in relevant interests and association of a substantial shareholder. It includes specific dates of changes in shareholding and signatures but does not contain financial statements or performance data. This type of filing is a notification of changes in significant share ownership levels, fitting the definition of Major Shareholding Notification (MRQ). The document length is 4091 characters, which is consistent with a detailed notification rather than a brief announcement or a full report. Therefore, the correct classification is MRQ.
2023-06-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.